ThinkSabio

$VTGN

$0.37▲ -2.6% YTD

5 SEC 13D/G filings tracked · Last updated Sep 24, 2026

Filing History
News
VTGN ▼ -2.6% - Vistagen Therapeutics, Inc.
CP $0.37▲ -2.6%Sep 24, 2026 · ThinkSabio Blog

$VTGN - Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder…

News
VTGN ▲ +13.0% - Vistagen Therapeutics, Inc.
CP $0.26▲ +13.0%Sep 22, 2026 · ThinkSabio Blog

$VTGN - Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatme…

SEC 13D/G
VTGN - Vistagen Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified
$0.26▼ -61.76%Aug 14, 2026 · ThinkSabio Blog

$VTGN SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #VTGN Vistagen Therapeutics, Inc. : $0.26 Sector: Healthcare | Y…

SEC 13D/G
VTGN - Vistagen Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified
$0.26▼ -61.76%Aug 14, 2026 · ThinkSabio Blog

$VTGN SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #VTGN Vistagen Therapeutics, Inc. : $0.26 Sector: Healthcare | Y…

SEC 13D/G
VTGN - Vistagen Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified
$0.27▼ -60.29%Aug 14, 2026 · ThinkSabio Blog

$VTGN SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #VTGN Vistagen Therapeutics, Inc. : $0.27 Sector: Healthcare | Y…